BCC Research

Could AI Finally Make Heart Disease Treatment Personal?

Could AI Finally Make Heart Disease Treatment Personal? Discover how AI is revolutionizing heart disease treatment, enabling personalized care and enhancing cardiovascular drug development in a complex healthcare landscape.

"Preventable hospitalizations from asthma and COPD represent one of the most persistent — and solvable — challenges in respiratory care. AI-enabled smart inhalers are rapidly becoming the infrastructure through which health systems, payers, and pharmaceutical companies intend to close that gap.

BCC Research's latest Pulse Report — *AI Impact on Smart Inhalers Global Market* — examines how machine learning, sensor analytics, and Software as a Medical Device (SaMD) platforms are reshaping respiratory disease management across the full care continuum.

Key findings from the report include:

- Adherium reported revenue of approximately $0.55 million in FY2024, reflecting a strategic shift toward U.S.-based commercial remote patient monitoring (RPM) services
- AptarGroup's R&D expenditure exceeded $580 million in 2024, spanning connected drug-delivery technologies supporting AI-enabled analytics
- Novo Nordisk acquired BioCorp, developer of Inspair smart sensors, to integrate connected device capabilities into its drug-delivery portfolio
- North America leads in market maturity, while Asia-Pacific is emerging as a high-growth region driven by rising respiratory disease prevalence and government-backed AI initiatives

Investors are increasingly treating smart inhaler platforms as infrastructure assets — prioritizing regulatory clearance, real-world deployment, and payer engagement over speculative capital. Emerging capabilities such as federated learning, predictive exacerbation risk scoring, and AI-driven population health management are setting the technical agenda for the next phase of adoption.

For industry analysts, investors, and strategic decision-makers tracking the intersection of digital health and respiratory care, this report offers a rigorous qualitative framework for understanding where value is being created — and where the barriers remain."

Download Report Overview: https://hubs.la/Q04p0rGX0

The $12.8 Billion Revolution Hiding in Plain Sight: Why Everyone's Talking About Microfactories

The $12.8 Billion Revolution Hiding in Plain Sight: Why Everyone's Talking About Microfactories Discover how microfactories are set to revolutionize manufacturing, driven by necessity and innovative technologies, with market growth projected at 16.2% annually.